CAH Stock Chart & Stats
$3995.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$2,686.00 - $4,165.79
Previous CloseN/A
VolumeN/A
Average Volume (3M)7.00
Market Cap
$933.77B
Enterprise Value$55.01K
Total Cash (Recent Filing)$3.94B
Total Debt (Recent Filing)$8.92B
Price to Earnings (P/E)34.8
Beta-0.56
Next Earnings
Aug 11, 2026EPS Estimate
42.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.56
Shares Outstanding234,205,860
10 Day Avg. Volume0
30 Day Avg. Volume7
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)-14.56
Price to Sales (P/S)0.18
P/FCF Ratio21.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4,421.78Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)211.43
Revenue Forecast (FY)$4.83T
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSustained, sizable operating and free cash flow provides durable internal funding for working capital, debt reduction, buybacks and acquisitions. This cash conversion reduces dependency on external financing and supports multi‑quarter execution of strategic initiatives and capital allocation.
Upgraded FY2026 Guidance & ProfitabilityManagement’s tighter, higher guidance reflects durable operational improvements and execution across Pharma and growth businesses. A credible uphill revision signals sustainable margin and cash‑flow leverage that can underwrite reinvestment and disciplined capital returns over the next several quarters.
Diversifying Specialty/Growth Businesses And M&ATargeted deals and rapid growth in Specialty/Other growth businesses broaden revenue mix and add direct‑to‑patient and specialty capabilities. Structural diversification reduces reliance on commodity distribution and can raise recurring, higher‑margin revenue streams over a multi‑quarter horizon.
Bears Say
Weak Balance Sheet / Negative EquityNegative shareholders’ equity and large absolute debt materially weaken the capital cushion, distort leverage metrics and constrain financial flexibility. In adverse conditions this increases refinancing and rating risk and limits the company’s ability to absorb shocks or opportunistically invest.
Structurally Thin MarginsVery low absolute margins mean small revenue or cost shifts produce outsized earnings volatility. Distribution economics leave limited room for SG&A, tariff, or reimbursement headwinds, making profitability sensitive to mix, pricing and operational execution over coming quarters.
Tariff & Regulatory Profit Uncertainty (GMPD)Exposure to tariffs and evolving regulatory rulings creates an uncertain, potentially recurring drag on product distribution margins. Until refunds or policy clarity materialize, segment profitability and cash flow remain vulnerable to legal and policy outcomes beyond management’s operational control.
Cardinal Health News
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $2686.00 and its highest was $4165.79 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $933.77B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Aug 11, 2026 which is in 17 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Apr 30, 2026. The company reported $55.503 earnings per share for the quarter, beating the consensus estimate of $48.937 by $6.566.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health does not currently pay dividends.
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 42.35.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 234,205,860 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $55.503 in its last earnings report, beating expectations of $48.937. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in MX:CAH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cardinal Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4,421.78 (― Downside)
$4,421.78 (― Downside)
Blogger Sentiment
Bullish
MX:CAH Sentiment 70%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.73%
12-Months-Change
Fundamentals
Return on Equity
0.86%
Trailing 12-Months
Asset Growth
13.67%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
CAH Revenue Breakdown
91.94% Pharmaceutical and Specialty Solutions
5.68% Global Medical Products and Distribution
2.42% Other
-0.04% Corporate

CAH Stock 12 Month Forecast
Average Price Target
$4,421.78



